ID   HCK_MACFA               Reviewed;         504 AA.
AC   Q95M30;
DT   23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   07-APR-2021, entry version 127.
DE   RecName: Full=Tyrosine-protein kinase HCK;
DE            EC=2.7.10.2;
DE   AltName: Full=Hematopoietic cell kinase;
DE   AltName: Full=Hemopoietic cell kinase;
DE   AltName: Full=p56-HCK;
GN   Name=HCK;
OS   Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC   Cercopithecidae; Cercopithecinae; Macaca.
OX   NCBI_TaxID=9541;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Picard C.;
RL   Thesis (2001), University of Marseille, France.
CC   -!- FUNCTION: Non-receptor tyrosine-protein kinase found in hematopoietic
CC       cells that transmits signals from cell surface receptors and plays an
CC       important role in the regulation of innate immune responses, including
CC       neutrophil, monocyte, macrophage and mast cell functions, phagocytosis,
CC       cell survival and proliferation, cell adhesion and migration. Acts
CC       downstream of receptors that bind the Fc region of immunoglobulins,
CC       such as FCGR1A and FCGR2A, but also CSF3R, PLAUR, the receptors for
CC       IFNG, IL2, IL6 and IL8, and integrins, such as ITGB1 and ITGB2. During
CC       the phagocytic process, mediates mobilization of secretory lysosomes,
CC       degranulation, and activation of NADPH oxidase to bring about the
CC       respiratory burst. Plays a role in the release of inflammatory
CC       molecules. Promotes reorganization of the actin cytoskeleton and actin
CC       polymerization, formation of podosomes and cell protrusions. Inhibits
CC       TP73-mediated transcription activation and TP73-mediated apoptosis.
CC       Phosphorylates CBL in response to activation of immunoglobulin gamma Fc
CC       region receptors. Phosphorylates ADAM15, BCR, ELMO1, FCGR2A, GAB1,
CC       GAB2, RAPGEF1, STAT5B, TP73, VAV1 and WAS (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Subject to autoinhibition, mediated by
CC       intramolecular interactions involving the SH2 and SH3 domains. Kinase
CC       activity is also regulated by phosphorylation at regulatory tyrosine
CC       residues. Phosphorylation at Tyr-389 is required for optimal activity.
CC       Phosphorylation at Tyr-500 inhibits kinase activity (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with ADAM15. Interacts with FASLG. Interacts with
CC       ARRB1 and ARRB2. Interacts with FCGR1A; the interaction may be
CC       indirect. Interacts with IL6ST. Interacts (via SH3 domain) with ELMO1.
CC       Interacts (via SH3 domain) with TP73. Interacts with YAP1. Interacts
CC       with ABL1 and ITGB1, and thereby recruits ABL1 to activated ITGB1.
CC       Interacts (via SH2 domain) with FLT3 (tyrosine phosphorylated).
CC       Interacts with CBL. Interacts with VAV1, WAS and RAPGEF1. Interacts
CC       (via SH3 domain) with WDCP. {ECO:0000250|UniProtKB:P08103,
CC       ECO:0000250|UniProtKB:P08631}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle
CC       {ECO:0000250}. Cytoplasm, cytosol {ECO:0000250}. Cell membrane; Lipid-
CC       anchor. Membrane, caveola {ECO:0000250}; Lipid-anchor {ECO:0000250}.
CC       Cell junction, focal adhesion {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Golgi apparatus {ECO:0000250}. Cytoplasmic vesicle
CC       {ECO:0000250}. Lysosome {ECO:0000250}. Nucleus {ECO:0000250}. Note=A
CC       small fraction is associated with caveolae. Localization at the cell
CC       membrane and at caveolae requires palmitoylation at Cys-3. Colocalizes
CC       with the actin cytoskeleton at focal adhesions (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on several tyrosine residues. Autophosphorylated.
CC       Becomes rapidly phosphorylated upon activation of the immunoglobulin
CC       receptors FCGR1A and FCGR2A. Phosphorylation at Tyr-389 increases
CC       kinase activity. Phosphorylation at Tyr-500 inhibits kinase activity.
CC       Kinase activity is not required for phosphorylation at Tyr-500,
CC       suggesting that this site may be a target of other kinases (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by CBL, leading to its degradation via the
CC       proteasome. {ECO:0000250}.
CC   -!- PTM: Palmitoylation requires prior myristoylation. Palmitoylation is
CC       required for caveolar localization (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. SRC subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ320181; CAC44031.1; -; mRNA.
DR   RefSeq; NP_001306372.1; NM_001319443.1.
DR   BMRB; Q95M30; -.
DR   SMR; Q95M30; -.
DR   STRING; 9541.XP_005568712.1; -.
DR   PRIDE; Q95M30; -.
DR   GeneID; 102115729; -.
DR   KEGG; mcf:102115729; -.
DR   CTD; 3055; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   BRENDA; 2.7.10.2; 1793.
DR   Proteomes; UP000233100; Unplaced.
DR   GO; GO:0005901; C:caveola; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IEA:RHEA.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0006909; P:phagocytosis; IEA:UniProtKB-KW.
DR   GO; GO:2000251; P:positive regulation of actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0050764; P:regulation of phagocytosis; ISS:UniProtKB.
DR   GO; GO:0071801; P:regulation of podosome assembly; ISS:UniProtKB.
DR   CDD; cd10363; SH2_Src_HCK; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR035851; HCK_SH2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00326; SH3; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding; Cell junction; Cell membrane; Cytoplasm; Cytoplasmic vesicle;
KW   Cytoskeleton; Exocytosis; Golgi apparatus; Immunity; Inflammatory response;
KW   Innate immunity; Kinase; Lipoprotein; Lysosome; Membrane; Myristate;
KW   Nucleotide-binding; Nucleus; Palmitate; Phagocytosis; Phosphoprotein;
KW   Proto-oncogene; Reference proteome; SH2 domain; SH3 domain; Transferase;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..504
FT                   /note="Tyrosine-protein kinase HCK"
FT                   /id="PRO_0000088103"
FT   DOMAIN          56..116
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          122..219
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   DOMAIN          240..493
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   NP_BIND         246..254
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        359
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         268
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         15
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   MOD_RES         30
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   MOD_RES         180
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   MOD_RES         187
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08103"
FT   MOD_RES         389
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   MOD_RES         440
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   MOD_RES         500
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08631"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250"
FT   LIPID           3
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   504 AA;  57096 MW;  53B29322D2DE3423 CRC64;
     MGCMKSKFLQ AGGNTFSKTE TSANPHCPVY VPDPTSTIKP GPNSNNRNTP GIGEGSEDII
     VVALYDYEAI HHEDLSFQKG DQMVVLEESG EWWKARSLAT RKEGYIPSNY VARVDSLETE
     EWFFKGISRK DAERQLLAPG NMLGSFMIRD SETTKGSYSL SVRDYDPRQG DTVKHYKIRT
     LDNGGFYISP RSTFSTLQEL VDHYKKGSDG LCQKLSVPCV SSKPQKPWEK DAWEIPRESL
     KLEKKLGAGQ FGEVWMATYN KHTKVAVKTM KPGSMSVEAF LAEANLMKTL QHDKLVKLHA
     VVTKEPIYII TEFMAKGSLL DFLKSDEGSK QPLPKLIDFS AQIAEGMAFI EQRNYIHRDL
     RAANILVSAS LVCKIADFGL ARIIEDNEYT AREGAKFPIK WTAPEAINFG SSTIKSDVWS
     FGILLMEIVT YGRIPYPGMS NPEVIRALER GYRMPRPENC PEELYNIMMR CWKNRPEERP
     TFEYIQSVLD DFYTATESQY QQQP
//
